1997PubMedRequires access

[Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].

Motero Carrasco J

Open publisher page 0 citations

Abstract

OBJECTIVE: To compare the antihypertensive efficacy of lisinopril (L) versus enalapril (E) given 20 mg once daily for the treatment of mild to moderate arterial hypertension (diastolic blood pressure between 90-114 mm Hg) using ambulatory blood pressure monitoring (ABPM). This study also investigated the tolerance and changes in haematological or biochemical parameters with both drugs. METHODS: One hundred patients (men and women) with a range of age between 18 to 75 years were included in this open, randomised study to assess the hypotensive efficacy of L versus E after 2 months of treatment, using ambulatory blood pressure monitoring. To study data obtained from ABPM Mc Call curves were used and statistical analysis was made using SPSS program. Covariance and Chi-square test were used for the comparative analysis of different variables, considering as significant value p < 0.05. Graphics were made using HG 3.0 version. All patients gave their informed consent to participate in the study. The protocol was approved by the Ethical Committee of the Clinic Hospital. RESULTS: Systolic blood pressure (SBP) decreased from 179.00 to 156.96 mm Hg in the Lisinopril group (p < 0.001) and from 176.65 to 149.20 mm Hg in the Enalapril group (p < 0.001). Diastolic blood pressure (DBP) decreased from 104.96 to 89.94 mm Hg in the L group (p < 0.001) and from 104.16 to 86.20 mm Hg in the E group (p < 0.001). Using ABPM mean SBP daily decreased from 163.86 to 132.26 mm Hg with L (p < 0.001) and from 156.65 to 136.18 mm Hg with E (p < 0.001). Mean DBP daily decreased from 99.23 to 87.51 mm Hg with L (p < 0.001) and from 96.55 to 87.24 with E (p < 0.001). Decreases were found from total cholesterol in both groups (from 218.46 to 207.29 mg/dl with L and from 220.59 to 205.19 mg/dl with E) (p < 0.05) and Cholesterol-LDL in the E group (150.44 to 138.88) (p < 0.05). CONCLUSIONS: Both drugs produce a fall of blood pressure in mild-to-moderate hypertension, although using ABPM this fall is more significant with. According to McCall index 73.45% of patients in the Lisinopril group and 69.26% of Enalapril group controlled their hypertension, there was a difference found between BP values obtained in the clinic and those obtained using ABPM.

About this research paper

What this paper is about

OBJECTIVE: To compare the antihypertensive efficacy of lisinopril (L) versus enalapril (E) given 20 mg once daily for the treatment of mild to moderate arterial hypertension (diastolic blood pressure between 90-114 mm Hg) using ambulatory blood pressure monitoring (ABPM). This study also investigated the tolerance and changes in haematological or biochemical parameters with both drugs. METHODS: One hundred patients (men and women) with a range of age between 18 to 75 years were included in this open, randomised study to assess the hypotensive efficacy of L versus E after 2 months of treatment, using ambulatory blood pressure monitoring. To study data obtained from ABPM Mc Call curves were used and statistical analysis was made using SPSS program. Covariance and Chi-square test were used for the comparative analysis of different variables, considering as significant value p < 0.05. Graphics were made using HG 3.0 version. All patients gave their informed consent to participate in the study. The protocol was approved by the Ethical Committee of the Clinic Hospital. RESULTS: Systolic blood pressure (SBP) decreased from 179.00 to 156.96 mm Hg in the Lisinopril group (p < 0.001) and from 176.65 to 149.20 mm Hg in the Enalapril group (p < 0.001). Diastolic blood pressure (DBP) decreased from 104.96 to 89.94 mm Hg in the L group (p < 0.001) and from 104.16 to 86.20 mm Hg in the E group (p < 0.001). Using ABPM mean SBP daily decreased from 163.86 to 132.26 mm Hg with L (p < 0.001) and from 156.65 to 136.18 mm Hg with E (p < 0.001). Mean DBP daily decreased from 99.23 to 87.51 mm Hg with L (p < 0.001) and from 96.55 to 87.24 with E (p < 0.001). Decreases were found from total cholesterol in both groups (from 218.46 to 207.29 mg/dl with L and from 220.59 to 205.19 mg/dl with E) (p < 0.05) and Cholesterol-LDL in the E group (150.44 to 138.88) (p < 0.05). CONCLUSIONS: Both drugs produce a fall of blood pressure in mild-to-moderate hypertension, although using ABPM this fall is more significant with. According to McCall index 73.45% of patients in the Lisinopril group and 69.26% of Enalapril group controlled their hypertension, there was a difference found between BP values obtained in the clinic and those obtained using ABPM.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To compare the antihypertensive efficacy of lisinopril (L) versus enalapril (E) given 20 mg once daily for the treatment of mild to moderate arterial hypertension (diastolic blood pressure between 90-114 mm Hg) using ambulatory blood pressure monitoring (ABPM). This study also investigated the tolerance and changes in haematological or biochemical parameters with both drugs. METHODS: One hundred patients (men and women) with a range of age between 18 to 75 years were included in this open, randomised study to assess the hypotensive efficacy of L versus E after 2 months of treatment, using ambulatory blood pressure monitoring. To study data obtained from ABPM Mc Call curves were used and statistical analysis was made using SPSS program. Covariance and Chi-square test were used for the comparative analysis of different variables, considering as significant value p < 0.05. Graphics were made using HG 3.0 version. All patients gave their informed consent to participate in the study. The protocol was approved by the Ethical Committee of the Clinic Hospital. RESULTS: Systolic blood pressure (SBP) decreased from 179.00 to 156.96 mm Hg in the Lisinopril group (p < 0.001) and from 176.65 to 149.20 mm Hg in the Enalapril group (p < 0.001). Diastolic blood pressure (DBP) decreased from 104.96 to 89.94 mm Hg in the L group (p < 0.001) and from 104.16 to 86.20 mm Hg in the E group (p < 0.001). Using ABPM mean SBP daily decreased from 163.86 to 132.26 mm Hg with L (p < 0.001) and from 156.65 to 136.18 mm Hg with E (p < 0.001). Mean DBP daily decreased from 99.23 to 87.51 mm Hg with L (p < 0.001) and from 96.55 to 87.24 with E (p < 0.001). Decreases were found from total cholesterol in both groups (from 218.46 to 207.29 mg/dl with L and from 220.59 to 205.19 mg/dl with E) (p < 0.05) and Cholesterol-LDL in the E group (150.44 to 138.88) (p < 0.05). CONCLUSIONS: Both drugs produce a fall of blood pressure in mild-to-moderate hypertension, although using ABPM this fall is more significant with. According to McCall index 73.45% of patients in the Lisinopril group and 69.26% of Enalapril group controlled their hypertension, there was a difference found between BP values obtained in the clinic and those obtained using ABPM.

Key concepts: Lisinopril, Enalapril, Ambulatory blood pressure, Blood pressure, Medicine, Ambulatory, Internal medicine, Diastole

Related papers

Back to paper searchBrowse research topicsOriginal source
[Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril]. — Research Paper | ScholarLens